B1617

Covaxin less effective against B.1.617.2 variant responsible for second wave: Study

Researchers associated with ICMR-National Institute of Virology and Bharat Biotech  studied neutralization of the parental B.1 virus and variants of concern- B.1.351 and B.1.617.

published on : 8th June 2021

Only one of three COVID strains of B.1.617 first detected in India now a 'variant of concern': WHO

WHO said that available findings for lineages B.1.617.1 and B.1.617.2 were initially used to designate B.1.617 a global Variant of Concern (VOC) on May 11 this year.

published on : 2nd June 2021

WHO names COVID-19 variants first found in India as 'Kappa' and 'Delta'

The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an 'Indian Variant'.

published on : 1st June 2021

Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India.

published on : 22nd May 2021

Lockdown in Bolton city not ruled out to curb spread of B1.617.2 variant: UK health secretary

Bolton town has seen a sharp spike in infections since mid-April, Public Health England said.

published on : 16th May 2021

Indian Covid variant sparks concern, and questions

The name "Indian variant" describes a strain -- B.1.617 -- that in fact groups together three distinct subvariants sharing some, but not all, of several mutations.

published on : 15th May 2021

Covid double mutant at least twice as infectious as earlier variants, say Indian scientists

"For the public, what needs to be communicated very clearly is that there is a greater need to double mask and maintain social distancing as this virus is highly infectious," a senior scientist said.

published on : 8th May 2021

Covid second wave is nearing its peak: Noted virologist Dr T Jacob John

There is no evidence that the variants are evading immunity. Covaxin immunity has been proved to be effective against all new variants, says Dr John in this interview.

published on : 6th May 2021

New 'very infectious' COVID strain has had minimal effect in state: Andhra Pradesh government

The N440K is neither a 'variant of interest' nor is virulent now, the state Health Department has said quoting a study by the Centre for Cellular and Molecular Biology.

published on : 6th May 2021

COVID: Centre warns of 'inevitable' third wave, says time-frame for it can not be predicted

In a press briefing by the Ministry of Health Affairs on Wednesday, officials said the long COVID wave of such "ferocity" that the country was experiencing currently "was not predicted".

published on : 5th May 2021

N440K variant fades as B1617 picks up, say scientists on COVID-19 second wave

Divya Tej Sowpati, a scientist at CCMB said while N440K was indeed a mutation of concern in South India during and after the first wave, current data show it is replaced by new variants.

published on : 5th May 2021